Ipca Laboratories Limited

NSE IPCALAB.NS

Ipca Laboratories Limited Net Income Margin for the year ending March 31, 2024: 7.18%

Ipca Laboratories Limited Net Income Margin is 7.18% for the year ending March 31, 2024, a -4.86% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Ipca Laboratories Limited Net Income Margin for the year ending March 31, 2023 was 7.55%, a -50.77% change year over year.
Ipca Laboratories Limited Net Income Margin for the year ending March 31, 2022 was 15.33%, a -28.17% change year over year.
Ipca Laboratories Limited Net Income Margin for the year ending March 31, 2021 was 21.34%, a 60.48% change year over year.
Ipca Laboratories Limited Net Income Margin for the year ending March 31, 2020 was 13.30%, a 10.40% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

NSE: IPCALAB.NS

Ipca Laboratories Limited

CEO	Mr. Pranay Premchand Godha
IPO Date	Jan. 1, 1996
Location	India
Headquarters	125, Kandivli Industrial Estate
Employees	17,335
Sector	Health Care
Industries Pharmaceuticals

Description

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Key trends

Past 5 years